Literature DB >> 12207855

Cystic Lesions of the Pancreas.

William R. Brugge1.   

Abstract

Pancreatic cystadenomas are a group of benign, premalignant, and malignant cystic tumors of the pancreas. Serous cystadenomas are benign lesions that often do not require surgical excision unless they are complicated by bleeding, obstruction, or pain. Mucinous cystadenomas are premalignant lesions that may be surgically excised if there is a concern regarding malignant degeneration. However, it may be difficult to predict the timing and risk of malignant change. Also, it is controversial whether all mucinous cystadenomas should be resected. Cystadenocarcinomas should be surgically managed if they are resectable, that is, there is no evidence of metastatic disease. Intraductal papillary mucinous tumors share many features with mucinous cystadenomas. However, intraductal papillary mucinous tumors arise from the pancreatic duct and are often associated with a dilated pancreatic duct. These lesions are often managed with surgical resection, including total pancreatectomy for diffuse lesions with evidence of localized malignancy.

Entities:  

Year:  2002        PMID: 12207855     DOI: 10.1007/s11938-002-0020-3

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  37 in total

Review 1.  Intraductal papillary mucinous tumor of the pancreas.

Authors:  James J Farrell; William R Brugge
Journal:  Gastrointest Endosc       Date:  2002-05       Impact factor: 9.427

2.  Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas.

Authors:  E Cuillerier; C Cellier; L Palazzo; J Devière; P Wind; F Rickaert; P H Cugnenc; M Cremer; J P Barbier
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

3.  An aggressive resectional approach to cystic neoplasms of the pancreas.

Authors:  K D Horvath; J A Chabot
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

4.  Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas.

Authors:  R E Wilentz; J Albores-Saavedra; M Zahurak; M A Talamini; C J Yeo; J L Cameron; R H Hruban
Journal:  Am J Surg Pathol       Date:  1999-11       Impact factor: 6.394

5.  Surgical treatment of intraductal papillary-mucinous tumors of the pancreas.

Authors:  N Kanazumi; A Nakao; T Kaneko; S Takeda; A Harada; S Inoue; T Nagasaka; N Nakashima
Journal:  Hepatogastroenterology       Date:  2001 Jul-Aug

6.  CT features of malignant mucinous cystic tumors of the pancreas.

Authors:  C Procacci; G Carbognin; S Accordini; C Biasiutti; A Guarise; F Lombardo; C Ghirardi; R Graziani; N Pagnotta; R De Marco
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

7.  Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination.

Authors:  F Paye; A Sauvanet; B Terris; P Ponsot; V Vilgrain; P Hammel; P Bernades; P Ruszniewski; J Belghiti
Journal:  Surgery       Date:  2000-05       Impact factor: 3.982

8.  Immunohistochemical and molecular biological studies of serous cystadenoma of the pancreas.

Authors:  T Ishikawa; A Nakao; S Nomoto; J Hosono; A Harada; T Nonami; H Takagi
Journal:  Pancreas       Date:  1998-01       Impact factor: 3.327

9.  Solitary cystic tumor of the pancreas: EUS-pathologic correlation.

Authors:  K Koito; T Namieno; T Nagakawa; T Shyonai; N Hirokawa; K Morita
Journal:  Gastrointest Endosc       Date:  1997-03       Impact factor: 9.427

10.  Cystadenomas of the pancreas: is enucleation an adequate operation?

Authors:  M A Talamini; R Moesinger; C J Yeo; B Poulose; R H Hruban; J L Cameron; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.